Claire Wohlhueter-Brulle
Gentilly, 94255, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Identification of risk profiles for liver injury in adults with multiple sclerosis using artificial intelligence method.
Journal: Multiple sclerosis and related disorders
Published: May 05, 2025
Cytokine release syndrome risk model with T-cell engaging therapies.
Journal: Cytotherapy
Published: March 25, 2025
Brief Digital Solutions in Behavior Change Interventions for Type 2 Diabetes Mellitus: A Literature Review.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 27, 2021
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
Journal: Diabetes, obesity & metabolism
Published: March 16, 2020
Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient-level pooled analysis of EDITION 1, 2 and 3.
Journal: Diabetes, obesity & metabolism
Published: June 01, 2018
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.
Journal: Diabetes & metabolism
Published: May 01, 2018
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 02, 2018
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.
Journal: Diabetes care
Published: January 23, 2018
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: July 20, 2017
Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes.
Journal: Journal of diabetes science and technology
Published: September 25, 2016
Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey.
Journal: Journal of diabetes science and technology
Published: May 24, 2015
Last Updated: 09/26/2026